Literature DB >> 6468198

Estrogen and progestin receptors in colonic cancer?

T Wobbes, L V Beex, A M Koenders.   

Abstract

Adenocarcinomas of the large bowel in 28 consecutive patients were examined for the presence of estrogen and progestin receptor proteins. None of the specimens showed specific high affinity receptor binding. Our findings suggest that adenocarcinoma of the large bowel does not contain cytoplasmic receptor sites for estrogen and progestin.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6468198     DOI： 10.1007/bf02553846

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


  5 in total

1.  Type II oestrogen binding sites in human colorectal carcinoma.

Authors:  M Piantelli; R Ricci; L M Larocca; A Rinelli; A Capelli; S Rizzo; G Scambia; F O Ranelletti
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Oestrogen receptors in colorectal carcinoma.

Authors:  P M Dawson; S Shousha; S D Blair; G D Carter; J Jones; J Alaghband-Zadeh; N A Theodorou
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

3.  Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors.

Authors:  S Singh; M C Sheppard; M J Langman
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

4.  Androgen receptors in experimentally induced colon carcinogenesis.

Authors:  J R Izbicki; G Wambach; S R Hamilton; E Harnisch; R Hogenschurz; W Izbicki; J Kusche
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 5.  Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Authors:  Theodore Krasanakis; Taxiarchis Konstantinos Nikolouzakis; Markos Sgantzos; Theodore Mariolis-Sapsakos; John Souglakos; Demetrios A Spandidos; Christina Tsitsimpikou; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.